CD274 and non-small cell lung carcinoma: PD-L1 expression of NSCLC tumors was significantly associated with radiomics signature. For prediction of PD-L1 expression, the prediction model that combination of radiomics signature and clinicopathologic features for predicting PD-L1 expression resulted in AUC 0.848 in the validation cohort.